Physician profile
Anna Thyne
NPI 1124580766
$915.02
in general payments reported to CMS, 2019-2025
18 companies · $690 in 2025
The $690 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.86 · 2024: $166 · 2025: $690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $241.40 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $175.36 | 2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $73.11 | 2024 | Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.02 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $48.43 | 2024-2025 | Rexulti |
| Lundbeck LLC | $42.24 | 2024-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $36.04 | 2025 | Caplyta |
| Axsome Therapeutics, INC. | $36.02 | 2025 | Auvelity |
| Abbvie INC. | $33.23 | 2025 | |
| Pfizer INC. | $32.10 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.38 | 2025 | Jardiance |
| Merck Sharp & Dohme LLC | $21.62 | 2025 | Pifeltro |
| Exact Sciences Corporation | $20.98 | 2025 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $17.20 | 2025 | Zoryve |
| Lilly USA, LLC | $17.02 | 2025 | Mounjaro, Zepbound |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $16.31 | 2024 | Fanapt |
| Paratek Pharmaceuticals, INC. | $13.72 | 2025 | Nuzyra |
| Genentech USA, INC. | $8.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Thyne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.